花园生物
(300401)
| 流通市值：71.84亿 | | | 总市值：73.02亿 |
| 流通股本：5.35亿 | | | 总股本：5.44亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 276,882,853.78 | 1,237,398,520.91 | 935,701,786.71 | 635,361,170.79 |
| 营业收入 | 276,882,853.78 | 1,237,398,520.91 | 935,701,786.71 | 635,361,170.79 |
| 二、营业总成本 | 226,825,639.48 | 901,092,612.99 | 681,596,217.82 | 464,449,150.95 |
| 营业成本 | 141,567,139.52 | 549,062,452.11 | 418,730,351.87 | 279,912,545.19 |
| 税金及附加 | 3,643,364.06 | 23,247,522.37 | 14,593,212.62 | 12,644,917.75 |
| 销售费用 | 25,751,219.52 | 139,059,833.85 | 115,838,645.93 | 81,950,539.28 |
| 管理费用 | 19,837,922.47 | 97,889,332.32 | 69,298,156.54 | 48,682,514.49 |
| 研发费用 | 23,344,319.96 | 65,458,521.65 | 47,239,313.67 | 32,926,037.33 |
| 财务费用 | 12,681,673.95 | 26,374,950.69 | 15,896,537.19 | 8,332,596.91 |
| 其中:利息费用 | 7,350,949.47 | 32,469,237.04 | 23,502,503.38 | 15,178,227.23 |
| 其中:利息收入 | 2,598,022.53 | 8,236,921 | 6,159,974.93 | 4,009,489.84 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 458,657.53 | 3,769,473.98 | 2,633,331.51 | 1,957,663.02 |
| 加:投资收益 | 140,700.21 | 1,405,551.96 | 756,809.35 | 181,778.62 |
| 资产处置收益 | - | -2,239,186.79 | -2,131,924.97 | 159.58 |
| 资产减值损失(新) | 18,663.14 | -6,963,915.27 | -1,882,107.46 | -1,482,482.08 |
| 信用减值损失(新) | 3,119,163.98 | -2,590,632.95 | -2,358,275.57 | -1,171,076.19 |
| 其他收益 | 2,989,354.98 | 20,347,253.16 | 13,229,770.66 | 8,893,250.81 |
| 四、营业利润 | 56,783,754.14 | 350,034,452.01 | 264,353,172.41 | 179,291,313.6 |
| 加:营业外收入 | 137,555.11 | 6,183,889.7 | 6,109,956.95 | 6,167,983.43 |
| 减:营业外支出 | 6,616.92 | 3,717,284.61 | 1,635,118.41 | 82,423.02 |
| 五、利润总额 | 56,914,692.33 | 352,501,057.1 | 268,828,010.95 | 185,376,874.01 |
| 减:所得税费用 | 6,644,894.52 | 47,642,766.14 | 34,773,392.18 | 23,833,026.52 |
| 六、净利润 | 50,269,797.81 | 304,858,290.96 | 234,054,618.77 | 161,543,847.49 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 50,269,797.81 | 304,858,290.96 | 234,054,618.77 | 161,543,847.49 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 50,271,348.24 | 304,864,608.69 | 234,059,386.22 | 161,547,089.8 |
| 少数股东损益 | -1,550.43 | -6,317.73 | -4,767.45 | -3,242.31 |
| 扣除非经常损益后的净利润 | 47,834,757.03 | 290,179,777.09 | 221,230,043.59 | 149,525,626.58 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.09 | 0.56 | 0.43 | 0.3 |
| (二)稀释每股收益 | 0.09 | 0.51 | 0.4 | 0.28 |
| 九、综合收益总额 | 50,269,797.81 | 304,858,290.96 | 234,054,618.77 | 161,543,847.49 |
| 归属于母公司股东的综合收益总额 | 50,271,348.24 | 304,864,608.69 | 234,059,386.22 | 161,547,089.8 |
| 归属于少数股东的综合收益总额 | -1,550.43 | -6,317.73 | -4,767.45 | -3,242.31 |
| 公告日期 | 2026-04-18 | 2026-04-18 | 2025-10-18 | 2025-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |